Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited, established in 2000 and headquartered in Jinan, People's Republic of China, is a key enterprise focused on the research, development, manufacturing, and distribution of bioactive materials. The company's offerings include pharmaceutical-grade sodium hyaluronate, branded as Hyature. This versatile compound serves as an active pharmaceutical ingredient (API) or an excipient in various medicinal and medical device applications, such as ophthalmic solutions, intra-articular injections, anti-adhesive preparations, and topical treatments for wound healing and soft tissue augmentation. For the cosmetics industry, Bloomage BioTechnology supplies an array of cosmetic-grade sodium hyaluronate solutions (including Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA). These are incorporated into beauty products to enhance moisturizing properties, facilitate skin repair, combat signs of aging, and promote skin brightening. Furthermore, the company produces food-grade sodium hyaluronate (HAPLEX) for integration into dietary supplements, healthy foods, and general food products. Its portfolio also extends to food-grade gamma aminobutyric acid (Gabarelax), hyaluronic acid designed for oral care products (Biomoist), and a line of animal care products under the HYAPET brand.

CEO: Yan Zhao - https://www.bloomagebioactive.com